Canaccord Genuity downgrades Seattle Genetics (Nasdaq: SGEN) from Buy to Sell. PT lowered to $10.

Canaccord analyst says, "Punctuated by ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE